This content is machine translated Obesity The pounds tumble under incretin-based therapies Antiadiposita can effectively support the success of lifestyle interventions and thus close a treatment gap. In Switzerland, the GLP-1 RAs liraglutide and semaglutide are currently the most effective in the…
View Post 6 min This content is machine translated Type 2 diabetes: current trends Dual GIP/GLP-1 receptor agonist as an innovative therapeutic option The goals of individualized diabetes treatment today are not limited to achieving glycemic control, but many blood glucose-lowering drugs have clinically relevant additional benefits. Incretin-based therapies are particularly interesting for…
View Post 4 min This content is machine translated GLP-1 receptor agonists Jack of all trades in the fight against type 2 diabetes GLP-1 receptor agonists (RA) have been used in the treatment of diabetic patients since 2005. For patients, their introduction was a milestone, as GLP-1 RAs have the great advantage of…
